Related references
Note: Only part of the references are listed.Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain
Seung Min Shin et al.
GENE THERAPY (2022)
Development of New Benzylpiperazine Derivatives as σ1 Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects
Giuseppe Romeo et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
Antonino N. Fallica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity
Giuseppe Romeo et al.
MOLECULES (2021)
Pharmacological characterization of high-affinity σ1 receptor ligands with spirocyclic thienopyran and thienofuran scaffold
Dirk Schepmann et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2020)
Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo
Sebastiano Intagliata et al.
AAPS JOURNAL (2020)
Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research
Greer McKendrick et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice
Melissa A. Tapia et al.
PSYCHOPHARMACOLOGY (2019)
Sigma-1 Receptor Inhibition Reduces Neuropathic Pain Induced by Partial Sciatic Nerve Transection in Mice by Opioid-Dependent and - Independent Mechanisms
Inmaculada Bravo-Caparros et al.
FRONTIERS IN PHARMACOLOGY (2019)
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain
Thomas J. Cirino et al.
FRONTIERS IN PHARMACOLOGY (2019)
Use and Misuse of Opioids in Chronic Pain
Nora Volkow et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Jordi Bruna et al.
NEUROTHERAPEUTICS (2018)
Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
Silvia Castany et al.
SCIENTIFIC REPORTS (2018)
Novel Endomorphin Analogs Are More Potent and Longer-Lasting Analgesics in Neuropathic, Inflammatory, Postoperative, and Visceral Pain Relative to Morphine
Amy K. Feehan et al.
JOURNAL OF PAIN (2017)
Radiosynthesis and First-In-Human PET/MRI Evaluation with Clinical-Grade [18F]FTC-146
Bin Shen et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
Neuropathic pain
Luana Colloca et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies
Sebastiano Intagliata et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Abuse and Misuse of Pregabalin and Gabapentin
Kirk E. Evoy et al.
DRUGS (2017)
Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR
Sebastiano Intagliata et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Blockade of Cocaine or σ Receptor Agonist Self Administration by Subtype-Selective σ Receptor Antagonists
Jonathan L. Katz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Addressing the Opioid Epidemic
Lewis S. Nelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors
Shainnel O. Eans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
Further validation to support clinical translation of [18F]FTC-146 for imaging sigma-1 receptors
Bin Shen et al.
EJNMMI RESEARCH (2015)
S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice
Georgia Gris et al.
BEHAVIOURAL PHARMACOLOGY (2014)
Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release,in the spinal cord in rats
Alba Vidal-Torres et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Evaluation of sigma-1 Receptor Radioligand F-18-FTC-146 in Rats and Squirrel Monkeys Using PET
Michelle L. James et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studies
Montserrat Abadias et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration
Shainnel O. Eans et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Sigma 1 receptor: A new therapeutic target for pain
Daniel Zamanillo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Non-Analgesic Effects of Opioids: Opioid-induced Respiratory Depression
Merel Boom et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
New Positron Emission Tomography (PET) Radioligand for Imaging σ-1 Receptors in Living Subjects
Michelle L. James et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
VETERINARY CLINICAL PATHOLOGY (2012)
Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats
Shiou-Lan Chen et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Identification of Two Novel, Potent, Low-Liability Antinociceptive Compounds from the Direct In Vivo Screening of a Large Mixture-Based Combinatorial Library
Kate J. Reilley et al.
AAPS JOURNAL (2010)
Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice
Michelle R. Hoot et al.
BRAIN RESEARCH (2010)
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
Ian Gilron et al.
LANCET (2009)
Central sensitization needs sigma receptors
Eva Drews et al.
PAIN (2009)
Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury
Beatriz de la Puente et al.
PAIN (2009)
Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions
Ian Gilron
CURRENT OPINION IN ANESTHESIOLOGY (2007)
Genome-wide atlas of gene expression in the adult mouse brain
Ed S. Lein et al.
NATURE (2007)
Influence of nociception and stress-induced antinociception on genetic variation in isoflurane anesthetic potency among mouse strains
JS Mogil et al.
ANESTHESIOLOGY (2005)
Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains
C Orsini et al.
PSYCHOPHARMACOLOGY (2005)
The magnitude of mechanical allodynia in a rodent model of lumbar radiculopathy is dependent on strain and sex
ML LaCroix-Fralish et al.
SPINE (2005)
Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL/6J mice
C Brabant et al.
PSYCHOPHARMACOLOGY (2005)
Comorbidities in chronic neuropathic pain
B Nicholson et al.
PAIN MEDICINE (2004)
The sigma1 (σ1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming
P Romieu et al.
PSYCHOPHARMACOLOGY (2004)
Neuropathic pain activates the endogenous κ opioid system in mouse spinal cord and induces opioid receptor tolerance
M Xu et al.
JOURNAL OF NEUROSCIENCE (2004)
8-carboxamidocyclazocine: A long-acting, novel benzomorphan
JM Bidlack et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
T Maurice et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2002)
DREAM is a critical transcriptional repressor for pain modulation
HYM Cheng et al.
CELL (2002)
Share Paper
